Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2018

Sep 6, 2018

30786_dirs_2018-09-06_878e304a-6a00-44f2-94ac-e9b42a310ab6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2018-09-04

Reporting Person: TUMOLO ANNETTE (Executive Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-04 Restricted Stock Units $0 A 3000 Acquired Bio-Rad A Common Stock (3000) Direct
2018-09-04 Non-Qualified Stock Option (right to buy) $326.15 A 3000 Acquired 2028-09-04 Bio-Rad A Common Stock (3000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 982.3476 Direct

Footnotes

F1: Includes 29.0901, 27.0055, 29.0803 and 25.7907 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 9/30/17, 12/31/17, 3/29/18 and 6/29/18, respectively.

F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.

F3: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.